FDA Adverse Event Injury Summary report: N

INTRALASE FS2

MDR report key: 6652789 · Received June 20, 2017

Report

Report Number
3006695864-2017-00411
Event Type
Injury
Date Received
June 20, 2017
Date of Event
May 26, 2017
Report Date
September 11, 2017
Manufacturer
ABBOTT MEDICAL OPTICS
Product Code
HNO
PMA / PMN Number
K060372
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL INFORMATION: A CORPORATE REPRESENTATIVE FROM THE ACCOUNT CONTACTED TECHNICAL SUPPORT ON (B)(6) 2017 REPORTING SEVERAL ISSUES OF LOOSE EPITHELIUM FOLLOWING FLAP CREATION. APPLICATIONS SUPPORT MANAGER (ASM) VISITED THE SITE ON 8/18/2017 AND OBSERVED 24 EYES WITH NO EPITHELIAL ISSUES. DISCUSSED FLAP LIFT TECHNIQUE WITH SURGEON. GELLED THE SYSTEM AND MADE CHANGES TO BED ENERGY AND SIDE CUT ENERGY TO MAKE FLAP LIFT EASIER. SURGEON WAS PLEASED WITH THESE SETTINGS. TECHNICIAN WAS APPLYING 3-6 DROPS OF PROPARACAINE IN EACH EYE PRIOR TO THE PROCEDURE AND AGREES TO CHANGE AND USE ONE-TWO DROPS PER EYE INSTEAD. PER SURGEON¿S INFO EPITHELIAL ISSUES ARE NOT CONSISTENT AND OCCUR ON YOUNG PATIENTS AND OLDER. SOME HAVE CORNEAL DYSTROPHY THAT WOULD EXPLAIN THE PROBLEM BUT SOME HAVE NO PRE-EXISTING CONDITIONS. HE DOES NOT FEEL THE ISSUE IS CAUSED BY THE INTRALASE BUT FEELS HAVING AN EASIER FLAP LIFT WOULD DECREASE ANY EPITHELIAL DISRUPTION.

Additional Manufacturer Narrative · 1

(B)(4). THE CLINIC IS REPORTING THIS ADVERSE EVENT ONLY AND DID NOT REQUEST OR REQUIRE FIELD SERVICE OR CLINICAL SUPPORT. ALL PERTINENT INFORMATION AVAILABLE TO ABBOTT MEDICAL OPTICS HAS BEEN SUBMITTED.

Description of Event or Problem · 1

THE SURGERY CENTER REPORTED THAT A LASER VISION CORRECTION PATIENT PRESENTED WITH LOOSE EPITHELIUM ON BOTH EYES (OU) ON THE SAME DAY OF LASER TREATMENT. THE SURGERY CENTER NOTED LOOSE EPITHELIUM CENTRALLY ON BOTH EYES AND IT WAS LIKELY DUE TO SUBCLINICAL ANTERIOR BASEMENT MEMBRANE DYSTROPHY (ABMD).BANDAGE CONTACT LENS (BCL) WAS PLACED ON BOTH EYES. THE PATIENT WAS SEEN THE FOLLOWING DAY AND WAS STILL PRESENT. THE SURGERY CENTER HAD THE PATIENT CONTINUE THE WEAR OF THE BANDAGE CONTACT LENS. THE PATIENT RETURNED ON A 6 DAY POST OP EXAM AND THE LOOSE EPITHELIUM HAD NOT RESOLVED. THE PATIENT WAS TREATED WITH MURO OINTMENT AND TO CONTINUE THE OINTMENT. THE SURGERY CENTER CONFIRMED THE MURO IS OUTSIDE OF THE ROUTINE POST OP REGIMEN. PRE-OP BCVA FROM (B)(6) 2017: RIGHT EYE (OD) PRE-OP 20/20 -6.25 X -1.50 X 32; LEFT EYE (OS) PRE-OP 20/20 -7.00 X -.75 X 2.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
435362 INTRALASE FS2 FEMTOSECOND LASER HNO ABBOTT MEDICAL OPTICS 20003D

Patients

Seq Age Sex Outcome Treatment
1 54 YR Required Intervention WAVELIGHT SERIAL NO.(B)(4)